NO20054777L - Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser - Google Patents

Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser

Info

Publication number
NO20054777L
NO20054777L NO20054777A NO20054777A NO20054777L NO 20054777 L NO20054777 L NO 20054777L NO 20054777 A NO20054777 A NO 20054777A NO 20054777 A NO20054777 A NO 20054777A NO 20054777 L NO20054777 L NO 20054777L
Authority
NO
Norway
Prior art keywords
agent
pharmaceutical composition
fluid
antibacterial agent
otite
Prior art date
Application number
NO20054777A
Other languages
English (en)
Inventor
Niki Ann Waldron
Nancy Jean Britten
John W Burns
John W Haallberg
Jeffrey L Watis
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of NO20054777L publication Critical patent/NO20054777L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

En fremgangsmåte er tilveiebrakt for behandling av en infeksjonstUstand i et fluidinneholdende organ som har en naturlig eksteriøråpning, slik som et jur til et melkeproduserende dyr eller et øre. Fremgangsmåten innbefatter adminisfrering av et antibakterielt middel til organet via eksteriøråpningen og adminisfrere i kombinasjonsbehandling med det antibakterielle midlet et andre middel som er et anti- inflammasjonsmiddel, et analgesimiddel og/eller et antipyretisk middel. Det antibakterielle midlet og, eventuelt, det andre midlet, adminisfreres som en farmasøytisk sammensetning som ytterligere innbefatter en vehikel som innbefatter en amfipatisk olje som er vanndispergerbar og etanoluløsehg, mikrokrystallinsk voks og en farmasøytisk akseptabel ikke-vandig bærer. Også tilveiebrakt er en slik sammensetning som innbefatter det antibakterielle midlet og det andre midlet. Sammensetningen er lett dispergerbar i fluidet til det fluidinneholdende organet.
NO20054777A 2003-03-20 2005-10-17 Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser NO20054777L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45620103P 2003-03-20 2003-03-20
PCT/IB2004/000802 WO2004082719A1 (en) 2003-03-20 2004-03-10 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Publications (1)

Publication Number Publication Date
NO20054777L true NO20054777L (no) 2005-10-17

Family

ID=33030090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054777A NO20054777L (no) 2003-03-20 2005-10-17 Dispergerbar farmasoytisk sammesetning for behandling av mastitt og/eller otittforstyrrelser

Country Status (19)

Country Link
US (1) US20040214753A1 (no)
EP (1) EP1608406A1 (no)
JP (1) JP2006520778A (no)
KR (1) KR100765614B1 (no)
CN (1) CN1761486A (no)
AR (1) AR043651A1 (no)
AU (1) AU2004222518A1 (no)
BR (1) BRPI0408559A (no)
CA (1) CA2519589A1 (no)
CL (1) CL2004000471A1 (no)
CO (1) CO5611165A2 (no)
MX (1) MXPA05010019A (no)
NO (1) NO20054777L (no)
NZ (1) NZ541780A (no)
RU (1) RU2321423C2 (no)
TW (1) TWI265809B (no)
UY (1) UY28236A1 (no)
WO (1) WO2004082719A1 (no)
ZA (1) ZA200506531B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
BR0316976A (pt) * 2002-12-02 2005-10-25 Byocoat Entpr Inc Composição e método para tratamento de doença fúngica em planta
BRPI0408099B1 (pt) 2003-03-05 2014-04-08 Byocoat Entpr Inc Solução antimicrobiana e processo
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
MXPA06012215A (es) * 2004-04-22 2007-04-19 Pfizer Prod Inc Metodo de estabilizacion de la sal sodica cefovecina desordenada.
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
WO2008035370A2 (en) * 2006-07-10 2008-03-27 Advanced Enzyme Technologies Limited Compositions for prevention and treatment of mastitis and metritis
KR101461842B1 (ko) * 2007-02-08 2014-11-13 메드트로닉 좀드 인코퍼레이티드 의료용 용매화 시스템 및 실런트
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
BRPI0700969A (pt) * 2007-03-22 2008-11-04 Ouro Fino Participacoes E Empr composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
WO2009045456A1 (en) * 2007-10-03 2009-04-09 Byocoat Enterprises, Inc. Compositions and methods for treating mastitis
US8784790B2 (en) 2008-06-12 2014-07-22 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
US8318817B2 (en) * 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
CN101953784B (zh) * 2009-07-16 2012-02-08 中国农业大学 含阿莫西林、硫酸粘菌素和泼尼松龙的兽用混悬液及其制备方法
MX2012004177A (es) 2009-10-12 2012-05-08 Boehringer Ingelheim Vetmed Recipiente para composiciones que comprenden meloxicam.
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
BRPI1103782A2 (pt) * 2011-08-19 2013-07-30 Eurofarma Lab Ltda produto veterinÁrio para tratamento de mastite, pre composiÇço antibiàtica a anti inflamatària, kit, mÉtodo de preparaÇço uso e mÉtodo de tratamento de mastite
CN102784161A (zh) * 2012-08-01 2012-11-21 张吉川 一种治疗急慢性中耳炎的特效滴耳液
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
CN104825474B (zh) * 2015-04-30 2018-02-06 中国农业科学院兰州畜牧与兽药研究所 一种治疗动物体表损伤的药物组方及其制备工艺
MX370083B (es) * 2015-05-06 2019-11-29 Zoetis Services Llc Formulacion de hidrogel con adhesion moderada.
US10434097B1 (en) 2015-09-14 2019-10-08 Gateway Biotechnology, Inc. Methods and compositions for treating hearing disorders
IL265109B2 (en) 2016-09-13 2024-05-01 Allergan Inc Stabilized non-protein clostridial toxin compositions
CN107252441A (zh) * 2017-08-07 2017-10-17 咸阳职业技术学院 一种治疗奶牛乳腺炎的药物组合物及其制备方法
WO2019126783A1 (en) * 2017-12-22 2019-06-27 Otonomy, Inc. Triglyceride otic formulations and uses thereof
CA3132159C (en) * 2019-03-06 2023-11-21 Zoetis Services Llc A ready-to-use injectable formulation comprising cefovecin
EP4021446A4 (en) * 2019-08-27 2023-09-13 Kashiv Biosciences, LLC COMPOUNDS FOR TREATING PAIN
CN116421731B (zh) * 2023-04-07 2025-09-23 佛山市南海东方澳龙制药有限公司 用于防治奶牛乳房炎的药物组合物及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636194A (en) * 1969-10-23 1972-01-18 Douglas G Parizeau Composition and method for treating mastitis with therapeutic agents
DE2063896A1 (de) * 1970-12-28 1972-07-20 Dynamit Nobel Ag, 5210 Troisdorf Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung
IT1190445B (it) * 1985-11-08 1988-02-16 Fatro Spa Composizioni veterinarie a base di agenti antimicrobici e loro impiego
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
NZ331824A (en) * 1994-10-26 2000-01-28 Novartis Ag use of an unsaturated fatty alcohol to stabilise a macrolide in a pharmaceutical composition
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
CZ292320B6 (cs) * 1995-05-25 2003-09-17 G. D. Searle & Co. Způsob přípravy pyrazolů
ES2173287T3 (es) * 1995-06-06 2002-10-16 Bayer Ag Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas.
US5756529A (en) * 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
AP9700912A0 (en) * 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
WO1997038986A1 (en) * 1996-04-12 1997-10-23 G.D. Searle & Co. Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
RU2156131C1 (ru) * 1996-06-21 2000-09-20 Беляев Юрий Евгеньевич Полуфабрикат для получения основы лекарственного средства, основы лекарственного средства из этого полуфабриката (варианты) и лекарственное средство на этой основе (варианты)
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
US6395746B1 (en) * 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6440964B1 (en) * 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US7064132B2 (en) * 1999-11-28 2006-06-20 Scientific Development And Research, Inc. Composition and method for treatment of otitis external
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6649629B2 (en) * 1999-12-23 2003-11-18 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid
US6548527B2 (en) * 2000-03-27 2003-04-15 The General Hospital Corporation Treatments for immune-mediated ear disorders
EP2241328A1 (en) * 2000-05-12 2010-10-20 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
AU2001274858A1 (en) * 2000-06-08 2001-12-17 Board Of Regents, The University Of Texas System Heterocycle derivatives and methods of use for treating anthrax infection
DE60131537T2 (de) * 2000-06-22 2008-10-23 Nitromed, Inc., Lexington Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions

Also Published As

Publication number Publication date
NZ541780A (en) 2008-06-30
AU2004222518A1 (en) 2004-09-30
JP2006520778A (ja) 2006-09-14
AR043651A1 (es) 2005-08-03
RU2005126363A (ru) 2006-05-10
TWI265809B (en) 2006-11-11
BRPI0408559A (pt) 2006-03-21
TW200507852A (en) 2005-03-01
UY28236A1 (es) 2004-11-08
MXPA05010019A (es) 2005-11-17
CO5611165A2 (es) 2006-02-28
CA2519589A1 (en) 2004-09-30
CL2004000471A1 (es) 2005-04-22
KR100765614B1 (ko) 2007-10-09
WO2004082719A1 (en) 2004-09-30
RU2321423C2 (ru) 2008-04-10
US20040214753A1 (en) 2004-10-28
CN1761486A (zh) 2006-04-19
EP1608406A1 (en) 2005-12-28
KR20050114245A (ko) 2005-12-05
ZA200506531B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
NO20054260L (no) Disepergebar formulering av en anti-inflammatorisk forbindelse
NO20052306L (no) Dispergerbare farmasoytiske blandinger.
TWI265809B (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
NO20060982L (no) Dispergerende formulering for et anti-inflammatorisk middel
NO20065505L (no) Apparat og fremgangsmate for kirugisk forbedring av vandig vaeskedrenering.
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
AR058679A1 (es) Preparacion farmaceutica que contiene meloxicam
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
BRPI0407485A (pt) utilização de anticorpos anti-receptores de factor crescimento i semelhantes aos anti-insulina
MX2007005570A (es) Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y manejo de padecimientos parasiticos.
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
NO336678B1 (no) Anvendelse av ekstraherte botaniske antocyanosider, sanguariner og keleritriner for fremstilling av sammensetninger til munnhygiene
NO20072864L (no) En transmukosal veterinaersammensetning som omfatter detomidin
BRPI0412694A (pt) compostos
NO20083784L (no) Nytt sitratsalt av en indol derivativ og den farmasoytiske bruken derav
WO2006102438A3 (en) Methods and compositions for irrigation of mucosal tissues
EA200801890A1 (ru) Средство для лечения шума в ушах
NO20052960L (no) Anvendelse av dokosahekasensyre som aktivt stoff til behandling av lipodystrofi
BRPI0412923A (pt) composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos
NO20073757L (no) Topiske vaginale farmasoytiske sammensetninger
MD2516B1 (en) Anti-inflammatory, antiseptic and antimycotic medicament in the form of gel
MA49754B1 (fr) Méthodes de traitement de symptômes de gastroparésie au moyen de velusetrag
Callejo et al. Considerations on acute otitis externa for its optimized treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application